Ombelet W
Editor-in-Chief; Genk Institute for Fertility Technology, ZOL Hospitals, Schiepse Bos 6, 3600 Genk, Belgium.
Facts Views Vis Obgyn. 2016 Dec;8(4):189-191.
The epidemic of iatrogenic multiple births as a result of infertility treatment are responsible for an unacceptable high incidence of maternal, perinatal and childhood morbidity and mortality. Healthcare costs due to infertility therapy are too high and this may lead to social and political concern. The introduction of single embryo transfer (SET) was a real breakthrough, but was only accepted in most European countries and Japan. The United States, Latin America and most developing countries still have high multiple pregnancy rates. The most common argument for not performing SET are the high costs associated with ART procedures. Competition between ART centres to achieve and publish the highest success rates is another major factor. But things have changed: vitrification methods for cryopreservation are responsible for a better survival and increased success rate with frozen-embryo transfer, our knowledge to select the best embryo for SET is increasing and the growing concern of health care providers and governments can be expected in the near future. Infertility specialists are supposed to deliver healthy, preferably singleton babies at the lowest cost. Misuse of science still reveals the dark side of ART in too many centres. There is enough evidence that reimbursement policies providing accessible ART to infertile couples can decrease the potential harm from multiple pregnancies substantially unless we succeed to provide simplified IVF at affordable prices.
不孕症治疗导致的医源性多胎妊娠流行,造成了孕产妇、围产期和儿童发病率及死亡率高得令人无法接受。不孕症治疗的医疗成本过高,这可能引发社会和政治关注。单胚胎移植(SET)的引入是一项真正的突破,但在大多数欧洲国家和日本才被接受。美国、拉丁美洲和大多数发展中国家的多胎妊娠率仍然很高。不进行SET的最常见理由是辅助生殖技术(ART)程序相关的高成本。ART中心之间为实现并公布最高成功率而展开的竞争是另一个主要因素。但情况已经发生了变化:冷冻保存的玻璃化方法提高了冻融胚胎移植的存活率和成功率,我们选择最佳胚胎进行SET的知识不断增加,预计医疗服务提供者和政府在不久的将来会越来越关注这一问题。不孕症专家应以最低成本接生健康的婴儿,最好是单胎婴儿。在太多中心,科学的滥用仍然暴露出ART的阴暗面。有充分证据表明,为不孕夫妇提供可及的ART的报销政策可以大幅降低多胎妊娠的潜在危害,除非我们成功以可承受的价格提供简化的体外受精(IVF)。